LITB [LightInTheBox] FWP: (Original Filing)

[Issuer Free Writing Prospectus Registration No.333-187965 May24, 2013 LightInTheBoxLtd. This free writing prospectus reflects the following amendment that was made in Amendment No.3 to ourmpanys registration statement on FormF-1, or Amendment No.3, filed via EDGAR with the SEC on May24, 2013. Reference to thever pageis to thever pageof the preliminary prospectus, which forms part of]

LITB [LightInTheBox] FWP: Issuer Free Writing Prospectus Registration No.333-187965 May24, 2013

[Issuer Free Writing Prospectus Registration No.333-187965 May24, 2013 LightInTheBoxLtd. This free writing prospectus reflects the following amendment that was made in Amendment No.3 to ourmpanys registration statement on FormF-1, or Amendment No.3, filed via EDGAR with the SEC on May24, 2013. Reference to thever pageis to thever pageof the preliminary prospectus, which forms part of]

By | 2016-02-05T23:10:33+00:00 May 24th, 2013|Categories: Chinese Stocks, LITB, Webplus ver|Tags: , , , , , |0 Comments

LITB [LightInTheBox] F-1/A: (Original Filing)

[Amendment No.3 to FormF-1 REGISTRATION STATEMENT LightInTheBoxCo.,Ltd.yman Islands 5961 Not Applicable Building 2, Area D, Floor 1-2, Diantong Times Square Law Debenturerporate ServicesInc.pies to: Leiming Chen, Esq.vidT. Zhang, Esq. Approximatete ofmmencement of proposedle to the public: o o o oLCULATION OF REGISTRATION FEE] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to the use in this Registration Statement on FormF-1 of our reportted April17, 2013 relating to thensolidated financial statements of LightInTheBoxLtd. and its subsidiaries, variable interest entities and variable interest entitys subsidiary and the financial statementhedule of LightInTheBoxLtd. for the years ended December31, 2010, 2011 and 2012,]

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines Beijing – May 24, 2013 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration] []

By | 2016-03-24T00:30:41+00:00 May 24th, 2013|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar